Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research. Bionano also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through our Bionano Laboratories business, wey also offer OGM-based diagnostic testing services.
We're tracking Bionano's market expansion
How Bionano's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
BionanoYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No tracked technology yet
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Bionano Genomics announces publication from Sanford Burnham Prebys Medical Discovery Institute on using Optical Genome Mapping to detect genomic alterations from gene editing technologies.
Bionano Genomics will host a conference call on March 23, 2026, to report Q4 and full year 2025 financial results and highlight recent corporate progress.
Diagens, a medical imaging AI company, goes public on HKEX, raising $101 million with shares up 104.65% on first day.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Bionano's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.